Research Topics
Species | JOHN PATTERSON ATKINSONSummaryAffiliation: Washington University School of Medicine Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Complement factor H and the hemolytic uremic syndromeJohn P Atkinson
Division of Rheumatology, Washington University School of Medicine, St Louis, MO 63110, USA
J Exp Med 204:1245-8. 2007..A mouse model of HUS designed to mirror human mutations in FH has now been developed, providing new understanding of the molecular pathogenesis of complement-related endothelial disorders...
Bypassing complement: evolutionary lessons and future implicationsJohn P Atkinson
Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Clin Invest 116:1215-8. 2006..These types of functional assays will eventually replace the more laborious, less physiologic, and less informative approaches currently in use to monitor complement activation...
C5a and Fcgamma receptors: a mutual admiration societyJohn P Atkinson
Washington University School of Medicine, St Louis, Missouri 63110 1093, USA
J Clin Invest 116:304-6. 2006..Thus, this work establishes a feedback loop whereby FcgammaR expression and function are enhanced, a very desirable event in concert with an infection but potentially deleterious in autoimmunity...
Complement system on the attack in autoimmunityJohn P Atkinson
Washington University School of Medicine, St Louis, Missouri 63110 1093, USA
J Clin Invest 112:1639-41. 2003..Specifically, interaction of complement component 5a (C5a) with its receptor is necessary for thrombosis of placental vasculature. Inhibition of complement activation may have a therapeutic role in this disease...
Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissueJohn P Atkinson
Washington University School of Medicine, Department of Medicine Rheumatology Division, 660 South Euclid Avenue, Campus Box 8045, St Louis, MO 63110, USA
Ann N Y Acad Sci 1056:144-52. 2005..By contrast, MCP deficiency can be corrected in part by a renal allograft. However, caution in the use of live-related donations is needed because of the high rates of incomplete penetrance of the described mutations...
Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of BbDennis E Hourcade
Washington University School of Medicine, Department of Medicine, Division of Rheumatology, St Louis, Missouri 63110, USA
J Biol Chem 277:1107-12. 2002..Mutations at the C3b.Bb interface interfere with the normal dissociation of C3b from Bb, whether it is spontaneous or promoted by DAF, CR1, or factor H...
Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneratioAnna Richards
Washington University School of Medicine, St Louis, Missouri, USA
Adv Immunol 96:141-77. 2007..A response to acute injury or chronic debris accumulation must be appropriately balanced. In either case, too much activation or too little regulation promotes undesirable tissue damage and human disease...
Membrane protein Crry maintains homeostasis of the complement systemXiaobo Wu
Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St Louis, MO 63110, USA
J Immunol 181:2732-40. 2008..They imply that there is constant turnover on cells of the AP pathway which functions as an immune surveillance system for pathogens and altered self...
Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndromeM Kathryn Liszewski
Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8045, St Louis, MO 63110, USA
Mol Immunol 44:1559-68. 2007..Our results add new information relative to the necessity for appropriate expression levels of MCP and further implicate the alternative pathway in disease processes such as aHUS...
Inhibiting complement activation on cells at the step of C3 cleavageM Kathryn Liszewski
Washington University School of Medicine, Department of Internal Medicine, Division of Rheumatology, 660 S Euclid, Box 8045, St Louis, MO 63110, USA
Vaccine 26:I22-7. 2008..This review describes lessons learned and the application of this model for functionally characterizing mutations in regulators associated with atypical hemolytic uremic syndrome...
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndromeCelia J Fang
Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
Blood 111:624-32. 2008..Both the R69W and A304V MCP mutations were deficient in their ability to control the alternative pathway of complement activation on a cell surface, illustrating the importance of modeling transmembrane proteins in situ...
Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachmentM Kathryn Liszewski
Department of Medicine Division of Rheumatology, Washington University School of Medicine, St Louis, MO 63110, USA
J Immunol 181:4199-207. 2008..These results provide insights related to the complement inhibitory activities of poxviral inhibitors of complement and describe a mAb with therapeutic potential...
Screening for complement system abnormalities in patients with atypical hemolytic uremic syndromeDavid Kavanagh
Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Clin J Am Soc Nephrol 2:591-6. 2007
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assemblyDirk Spitzer
Division of Rheumatology, Department of Medicine, School of Medicine, Washington University, St Louis, MO 63110, USA
J Immunol 179:2600-8. 2007..The properdin-directed model is consistent with a proposal made by Pillemer and his colleagues >50 years ago...
Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndromeDavid Kavanagh
Division of Rheumatology, Washington University School of Medicine, St Louis, MO 63110, USA
Mol Immunol 45:95-105. 2008..The excessive complement activation for a given degree of damage may result in generation of a procoagulant state and aHUS...
Advances in understanding of pathogenesis of aHUS and HELLPCelia J Fang
Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St Louis, MO 63110, USA
Br J Haematol 143:336-48. 2008....
Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysmMonica B Pagano
Department of Surgery, Section of Vascular Surgery, Washington University School of Medicine, St Louis, MO, USA
Circulation 119:1805-13. 2009..In this study, we tested the hypothesis that complement participates in the development of AAA by providing the necessary chemotactic signal that recruits neutrophils to the aortic wall...
Properdin homeostasis requires turnover of the alternative complement pathwayXiaobo Wu
Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Proc Natl Acad Sci U S A 107:19444-8. 2010..These findings represent an instructive example of how a positive regulator of an innate immune recognition and effector pathway is controlled. A rationale for such a means to supply properdin for immune reactions is proposed...
West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor HKyung Min Chung
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Proc Natl Acad Sci U S A 103:19111-6. 2006..Accordingly, extracellular NS1 may function to minimize immune system targeting of West Nile virus by decreasing complement recognition of infected cells...
Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapyDirk Spitzer
Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
J Immunol 177:4953-6. 2006..Thus, gene therapy with targeted regulators represents a treatment option to provide a long-term and sustained protein supply for the site-specific blockade of undesirable complement activation...
Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cellsMaria L Barilla-LaBarca
Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
J Immunol 168:6298-304. 2002..However, if the alternative pathway mediates C3b deposition, then MCP's cofactor activity is sufficient to restrict complement activation...
Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitorsMalgorzata Krych-Goldberg
Division of Rheumatology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
J Immunol 175:4528-35. 2005..These observations increase our understanding of the mechanism of DAA. In addition, a more potent decay-accelerating form of CR1 was generated...
CD46-induced human Treg enhance B-cell responsesAnja Fuchs
Department of Internal Medicine, Division of Rheumatology, Washington University School of Medicine, St Louis, MO, USA
Eur J Immunol 39:3097-109. 2009..Thus, the lack of cTreg function in optimizing B-cell responses could explain why some CD46-deficient patients develop common variable immunodeficiency...
Human complement receptor type 1 (CR1) binds to a major malarial adhesinMalgorzata Krych-Goldberg
Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110, USA
Trends Mol Med 8:531-7. 2002..Furthermore, structural differences in erythrocyte CR1 between human and non-human primates are probably explained by the selective pressure of malaria...
ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complementDirk Spitzer
Division of Rheumatology, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8045, St. Louis, MO 63110, USA
Mol Immunol 40:911-9. 2004..This approach should therefore be applicable for diseases caused by a membrane protein deficiency such as paroxysmal nocturnal hemoglobinuria (PNH)...
Targeted and restricted complement activation on acrosome-reacted spermatozoaRebecca C Riley-Vargas
Department of Medicine, Rheumatology Division, Washington University School of Medicine, St. Louis, Missouri 63110, USA
J Clin Invest 115:1241-9. 2005..In addition, we speculate that this "targeted and restricted" form of complement activation on host cells is a common strategy to handle modified self...
T-cell stimulation and regulation: with complements from CD46Claudia Kemper
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
Immunol Res 32:31-43. 2005..Herein, we review this pathway for the induction of Tregs, focusing on a role for the complement system and especially signaling through CD46 on human T-cells...
Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate EPanisadee Avirutnan
Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America
PLoS Pathog 3:e183. 2007..Differential binding of soluble NS1 by tissue endothelium and subsequent recognition by anti-NS1 antibodies could contribute to the selective vascular leakage syndrome that occurs during severe secondary DENV infection...
Emerging roles and new functions of CD46M Kathryn Liszewski
Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8045, St. Louis, MO 63110, USA
Springer Semin Immunopathol 27:345-58. 2005..Finally, highlighting its importance in protecting cells against excessive complement activation is the discovery that even a heterozygous deficiency of CD46 predisposes to hemolytic uremic syndrome...
In vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membraneDirk Spitzer
Department of Internal Medicine, Division of Rheumatology, Washington University School of Medicine, St Louis, MO 63110, USA
J Immunol 175:7763-70. 2005..These results suggest the possibility of using the single-chain Ab fragment-mediated targeting concept of complement regulatory proteins to restrict complement inhibition to the site of its excessive activation...
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards
Department of Medicine, Division of Rheumatology, Washington University School of Medicine, Campus Box 8045, 660 South Euclid Avenue, St Louis, MO 63110, USA
Mol Immunol 44:111-22. 2007..This highlights the importance of defining and characterizing the underlying genetic defects in patients with aHUS...
T-cell regulation: with complements from innate immunityClaudia Kemper
Washington University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Campus Box 8045, 660 South Euclid Avenue, Saint Louis, Missouri 63110, USA
Nat Rev Immunol 7:9-18. 2007..This Review focuses on the evolving role of the complement system in the regulation of T-cell responses, from directing the initiation phase, through driving lineage commitment, to regulating the contraction phase...
Research Grants
- ZAP70 IN T CELL DEVELOPMENTJohn Atkinson; Fiscal Year: 2002..Moreover, these studies may provide additional mechanistic information for therapeutic interventions in drug design for T cell lymphomas, immunodeficiencies, autoimmune diseases, and transplantation rejection. ..
